Clinical Conductor, the industry’s first collaborative and configurable CTMS for organizations managing or executing clinical trials, created by Bio-Optronics, a provider of software and services to healthcare and life sciences organizations around the world, has released a new Clinical Conductor CTMS revolutionizing clinical trial collaboration. The financial capabilities of Clinical Conductor also have been strengthened by the release and provide users enhanced levels of clarity and granularity of their trial finances, allowing them to maximize profitability and more easily ensure billing compliance.

Clinical Conductor provides research organizations with collaborative CTMS functionality that now brings all research components and partners together in real time. The collaborative qualities of Clinical Conductor are enhanced by the application’s new CTMS configurations. Now, sites, site networks, CROs and health systems will be fitted with a CTMS that contains the exact features and functionally required by their roles and responsibilities in clinical research.

“We are very proud to have been the first CTMS to provide the marketplace with the collaborative and financial functionality demanded by its users. This release further revolutionizes the way that’s done,” said Jeffrey Markin, vice president and chief operating officer at Bio-Optronics. “For example, whether the user is deploying a protocol centrally to multiple clinical sites conducting the study or aggregating study events and associated financial details, the new Clinical Conductor is designed to provide them with the proper tools to successfully navigate the increasing complexities and regulations of the clinical research industry.”

The new Clinical Conductor also has been fitted with important financial enhancements. These additions give users the granularity they need to capture all possible revenues and improve their business processes over time. This granularity will help organizations adhere to GCP guidelines and ensure accurate billing compliance is achieved. Specific additions also have been made that address the complexity of attributing payments and receivables to the proper sources in the complex clinical research and routine care environment. The financial functionality found in Clinical Conductor continues to make it possible for users to achieve maximum profitability while simultaneously conducting the highest quality research possible.